Rafferty Asset Management
WVE icon

Rafferty Asset Management’s Wave Life Sciences WVE Stock Holding History

Rafferty Asset Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$204K Buy
35,096
+24,676
+237% +$164K ﹤0.01% 1102
2026
Q1 		$75.5K Sell
10,420
-1,137
-10% -$14.8K ﹤0.01% 1052
2025
Q4 		$196K Sell
11,557
-5,064
-30% -$51.5K ﹤0.01% 1109
2025
Q3 		$122K Buy
16,621
+3,138
+23% +$25.4K ﹤0.01% 1094
2025
Q2 		$87.6K Buy
13,483
+312
+2% +$2.06K ﹤0.01% 1072
2025
Q1 		$106K Buy
13,171
+705
+6% +$7.71K ﹤0.01% 1044
2024
Q4 		$154K Buy
+12,466
New +$166K ﹤0.01% 1114

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Rafferty Asset Management's WVE Position: Q2 2026 in Review

Rafferty Asset Management increased its Wave Life Sciences (WVE) stake by 237% in Q2 2026, buying an estimated $164K and bringing the position to 35,096 shares worth $204K. The position accounts for ﹤0.01% of the portfolio, ranked #1102.

Rafferty Asset Management first reported a position in WVE in Q4 2024 and has held it in 7 quarters since. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Rafferty Asset Management held 35,096 shares of Wave Life Sciences worth $204K as of Q2 2026.
  • Rafferty Asset Management bought 24,676 Wave Life Sciences shares in Q2 2026, an estimated $164K.
  • Wave Life Sciences made up ﹤0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #1102 holding.
  • Rafferty Asset Management first reported a position in Wave Life Sciences in Q4 2024 and has held it in 7 quarters since.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.